SCHEMBL27857785

SCHEMBL27857785

CS(=O)(=O)c1nnc(-c2cccc(Cl)c2)o1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 4/20 0.59
▸ NPC1 O15118 2/20 0.59
▸ TP53 P04637 1/20 0.59
▸ TSHR P16473 1/20 0.59
▸ NFKB1 P19838 1/20 0.59
▸ NFKB2 Q00653 1/20 0.59
▸ RELA Q04206 1/20 0.59
▸ SMN1; SMN2 Q16637 1/20 0.59
▸ CA1 P00915 3/20 0.58
▸ CA2 P00918 3/20 0.58
▸ NOTUM Q6P988 4/20 0.58
▸ PIM1 P11309 1/20 0.49
▸ CA9 Q16790 2/20 0.48
▸ CA13 Q8N1Q1 2/20 0.48
▸ MAOB P27338 1/20 0.48
▸ KMT2A Q03164 1/20 0.46
▸ KDM4E B2RXH2 1/20 0.45
▸ ALDH1A1 P00352 1/20 0.45
▸ SLC9A1 P19634 1/20 0.44
▸ ATM Q13315 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27874334 0.82 NOTUM (0.54) RAB9ANPC1TSHRSMN1; SMN2CA1
SCHEMBL8590849 0.81 KDM4E (0.60) RAB9ANPC1TP53TSHRSMN1; SMN2
SCHEMBL408280 0.80 RAB9A (0.57) RAB9ANPC1TSHRNFKB1NFKB2
SCHEMBL18650263 0.80 NPC1 (0.89) RAB9ANPC1TP53TSHRNFKB1
SCHEMBL7830009 0.78 NOTUM (0.61) RAB9ANPC1SMN1; SMN2NOTUMMAOB
SCHEMBL9682102 0.77 NPC1 (0.66) RAB9ANPC1SMN1; SMN2CA1CA2
SCHEMBL28121986 0.76 RAB9A (0.56) RAB9ANPC1TP53TSHRNFKB1
SCHEMBL10039243 0.76 NPC1 (0.69) RAB9ANPC1TP53TSHRNFKB1
SCHEMBL27875906 0.75 VCP (0.47) RAB9ANPC1TP53TSHRNFKB1
SCHEMBL28371316 0.74 CA2 (1.00) RAB9ANPC1TP53TSHRNFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102499247-A Oxadiazole sulfone compound for controlling bacterial crop diseases UNIV GUIZHOU 2012-06-20 — — CN disclosed
Send feedback